The Biotech Growth Trust PLC (“the Company”)
Compliance with Market Abuse Regulation
7 October 2016
The Company confirms that:
a) all inside information which the Directors and Company may have had has been notified to a Regulated Information Service (“RIS”);
b) the Company’s net asset value per share is calculated and announced through a RIS on a daily basis;
c) the Company has no reason to believe that there will be any material difference between the net asset value per share as at close of business on 30 September 2016, which was announced on 3 October 2016, and the financial information to be published in the announcement of its results for the half year ended 30 September 2016.
Further to an announcement made on 3 October 2016 the Company is, therefore, not prohibited from dealing in its own securities during the closed period, as defined by the Market Abuse Regulation, which will end on the date of the publication of its results for the half year ended 30 September 2016, expected to be on or after 9 November 2016.
For further information please contact:
Victoria Hale Frostrow Capital LLP 020 3 170 8732